Orchestra BioMed Holdings Inc. (OBIO) — Financial Flexibility Index
Orchestra BioMed Holdings Inc. (OBIO) has a Financial Flexibility Index of -0.44x as of March 2026. Free cash flow of $-21.98 Million (operating CF $-22.17 Million minus capex $184.00K) represents 0% of total liabilities ($49.69 Million). Check OBIO capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Orchestra BioMed Holdings Inc. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Orchestra BioMed Holdings Inc. across 6 annual periods. See Orchestra BioMed Holdings Inc. (OBIO) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Orchestra BioMed Holdings Inc. (2020–2025)
Year-by-year free cash flow to debt coverage for Orchestra BioMed Holdings Inc.. For the full company profile including market capitalisation, see OBIO market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.94x | $-48.47 Million | $-48.96 Million | $51.48 Million | ▲ +19.1% |
| 2024 | -1.16x | $-50.27 Million | $-50.56 Million | $43.22 Million | ▲ +31.4% |
| 2023 | -1.69x | $-46.05 Million | $-46.13 Million | $27.17 Million | ▼ -154.2% |
| 2022 | -0.67x | $-28.70 Million | $-29.29 Million | $43.04 Million | ▼ -195.1% |
| 2021 | -0.23x | $-19.16 Million | $-19.43 Million | $84.76 Million | ▲ +23.7% |
| 2020 | -0.30x | $-25.64 Million | $-26.18 Million | $86.63 Million | — |